Search Results 41-50 of 8860 for ���������������������������:ZA31���

  1. A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma - Mayo Clinic

    About this study. The primary objectives of this study are to determine the maximum tolerated dose/recommended phase 2 dose (MTD/RP2D) of selumetinib + ...

  2. A Study Evaluating MM-310 in Patients With Solid Tumors - Mayo Clinic

    MM-310 is a liposomal formulation of a docetaxel prodrug that targets the EphA2 receptor on cancer cells. Docetaxel is an approved chemotherapeutic drug.This ...

  3. Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases - Mayo Clinic

    About this study. The purpose of this study is to create a repository for cerebellar ataxia and nucleotide repeat diseases in order to fully investigate the ...

  4. A Study to Evaluate Personalized Molecular Marker and Immunoprofiling to Transform Hepatocellular Carcinoma Treatment - Mayo Clinic

    The purpose of this study is to evaluate whether profiling aggressive tumors for molecular alterations, together with drug testing in patient-derived 3D models, ...

  5. A Study to Identify Discomforts Among Intensive Care Unit Patients - Mayo Clinic

    The primary purpose of this study is to assess and describe the contributing sources of discomfort(s) experienced by ICU patients utilizing the Discomforts ...

  6. A Study to Assess an MRI Image Localizer for 7T MRI Neuronavigation - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. A Study to Identify Late-Occurring Complications in Childhood Cancer Survivors - Mayo Clinic

    A patient's genes may affect the risk of developing complications, such as congestive heart failure, heart attack, stroke, and second cancer, years after ...

  8. Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC) - Mayo Clinic

    About this study. The North American Mitochondrial Disease Consortium (NAMDC) maintains a patient contact registry and tissue biorepository for patients ...

  10. A Clinical Use Application for the Humanitarian Use Device Exemption Use Protocol of TheraSphere for Treatment of Unresectable Primary or Secondary Liver Neoplasia - Mayo Clinic

    This protocol allows multiple treatments with TheraSphere® that may be delivered on an outpatient basis. Patients may receive a single dose to a liver lobe or ...